Bill

Bill > A730


NJ A730

Requires health insurers to cover Lyme disease.


summary

Introduced
01/11/2022
In Committee
01/11/2022
Crossed Over
Passed
Dead
01/08/2024

Introduced Session

2022-2023 Regular Session

Bill Summary

This bill requires hospital service corporations, medical service corporations, health service corporations, commercial insurers and health maintenance organizations to provide benefits for the treatment of Lyme disease determined to be medically necessary by the covered person's physician after making a written evaluation of that person's symptoms, condition and response to treatment. Treatment otherwise eligible for benefits pursuant to this bill could not be denied because such treatment may be characterized as experimental or investigational in nature.

AI Summary

This bill requires hospital service corporations, medical service corporations, health service corporations, commercial insurers, health maintenance organizations, and individual and group health insurance policies to provide benefits for the treatment of Lyme disease determined to be medically necessary by the covered person's physician. The treatment cannot be denied because it may be characterized as experimental or investigational in nature. The bill applies to all contracts and policies in which the insurer has reserved the right to change the premium.

Committee Categories

Business and Industry

Sponsors (4)

Last Action

Introduced, Referred to Assembly Financial Institutions and Insurance Committee (on 01/11/2022)

bill text


bill summary

Loading...

bill summary

Loading...
Loading...